Thanks RAN58. If I could make one more comment.
I've an interest in 2 biopharma, each with their own small hydrophobic molecule. I cannot pick between the molecules. They both have enormous promise, but they have found very different homes.
One is driven by the founder who drives it 10 hrs, 7 days ... lives and breath's the company. Always promoting, always driving, brilliant strategy, 4 clinical trials underway or indeed imminent, listed 2016, MCap $180m.
Our molecule compares I think, but not our urgency and drive. I'm not suggesting we should subtract anything from the company, more separate functions and add that energy and bulldog mindset. Don't expect a reply, but thanks for participating here. Cheers, Mike
MY INPUT REGARDING PAA AND SARS-COV-2., page-12
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $141.2K | 801.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 537419 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 140000 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |